Uncovering the mystery of migraine
It's a disease that has baffled health professionals for years, but our researchers have taken a significant step forward in understanding migraine.
MRI brain scan indicating area of the brain where GABA is measured
A new study, published in NMR in Biomedicine, reveals higher levels of the chemical gamma-aminobutyric acid in the brain of migraine sufferers, supporting the theory that migraines are linked to a chemical imbalance in the brain.
"The finding paves the way for the discovery of new, effective treatments for migraines," said lead researcher Maria Aguila, PhD candidate in the Faculty of Health Sciences.
"For such a debilitating condition, very little is known about migraine so this is a big step forward and could lead to better diagnosis and treatment of the disease in the future," she said.
Gamma-aminobutyric acid or GABA as it is commonly known, is the most abundant inhibitory brain chemical and has long been suspected to play a role in migraines due to its ability to influence pain. This study is the first to accurately measure GABA levels in the living brain.
"We still don't know what causes migraine, how it starts and ends, or why the triggers appear to differ from one person to the next, but this discovery means that we can now be much more specific with our research going forward," said Ms Aguila.
"For example, GABA could be used to help us identify migraine sufferers and track responses to drug trials, and measuring GABA levels over a period of time could well reveal what’s causing attacks.”
The study compared the levels of GABA in twenty chronic migraine sufferers to an age and gender matched control group who did not experience any form of regular headaches. Brain scans were conducted when the participants were not having a migraine.
The measurement of GABA levels in the brain was made possible by a novel spectroscopy technique associated with MRI developed by researchers at the University of Sydney Brain and Mind Centre.
Associate Professor in Neuroimaging, Jim Lagopoulos said the ability to directly measure these chemicals in the brain would not have been possible several years ago.
“These advances not only allow us to study fundamental changes in brain chemistry that are associated with migraine, but they also open a whole new world with respect to monitoring a patient's response to treatment and compliance," he said.
The researchers were unable to tell if the increase in GABA is related to a recent migraine attack or signalling a new one as the scanning process is currently too complex to carry out during a migraine attack.
The study design was conceived by Professor Kathryn Refshauge and executed by researchers from the University of Sydney’s Faculty of Health Sciences and Brain and Mind Centre, Neuroscience Research Australia, University of the Philippines and University of New South Wales.
Related articles
Surge in flu this winter
People suffering severe flu this winter should seek medical treatment as soon as possible.
$100,000 Writer in Residence Fellowship to combat obesity
Expressions of interest have opened for a $100,000 Writer in Residence Fellowship to join the fight against obesity, diabetes and cardiovascular disease.
NHMRC funding recognises University of Sydney's research excellence
This outstanding result includes funding of more than $7 million for three NHMRC centres of research excellence dedicated to the early prevention of obesity in childhood, protecting the public from emerging infectious diseases and creating a more sustainable healthcare system, with a focus on cardiovascular disease and cancer.
Thousands of dollars in scholarships still available for 2016
If you’re studying at Sydney next year there are numerous scholarships still open for new and current students across many study areas including engineering, the sciences, education, pharmacy, dentistry, nursing, medicine, social work, engineering, and business.
Dementia tsunami: Alzheimer's and other dementias to triple by 2050
Governments need to take action on delaying the onset of Alzheimer's disease and other dementias, argues Associate Professor Lesley Russell.
University continues to excel in Times Higher Education subject rankings
The excellence of our research, teaching and citations underpin our positioning in the Times Higher Education subject rankings.
Ready, set, Rio: Sydney cohort heads to the Games
As more than 3.5 billion people around the world turn their sights towards Rio this week, 30 athletes from our community are getting ready to take their place on the globe’s biggest sporting stage.
Australian study wants your view on personal genomic testing
Do you want to know about your genetic information? Would you share it?
Why now is the best time to go on a diet, or the science of post-holiday weight loss
Understanding the body's responses to excess energy intake could give you the edge for a successful New Year's resolution, says Associate Professor Amanda Salis.
Is obesity a disease?
Health and medical experts, industry and key decision makers will debate the classification of obesity when they gather at Obesity Australia's fifth annual summit at the University of Sydney’s Charles Perkins Centre on 22 June.